Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate

Schizophrenia Research - Tập 55 - Trang 25-40 - 2002
Monte S Buchsbaum1, Lina Shihabuddin1,2, Erin A Hazlett1, Johannes Schröder3, Mehmet M Haznedar1, Peter Powchik1,2, Jacqueline Spiegel-Cohen1, Tsechung Wei1, Melissa B Singer1, Kenneth L Davis1
1Neuroscience PET Laboratory and Department of Psychiatry, Mt. Sinai School of Medicine, Box 1505, One Gustave L. Levy Place, New York, NY 10029-6574, USA
2Psychiatry Service, Bronx DVA Medical Center, 130 W. Kingsbridge Road, Bronx, NY 10468, USA
3Department of Psychiatry, University of Heidelberg, Voss Str. 4, D-69115 Heidelberg 1, Germany

Tài liệu tham khảo

1987 Andreasen, 1992, The Comprehensive Assessment of Symptoms and History (CASH), Arch. Gen. Psychiatry, 49, 615, 10.1001/archpsyc.1992.01820080023004 Battig, 1969, 80 Bernstein, 1988 Buchsbaum, 1990, The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia, Schizophr. Bull., 16, 377, 10.1093/schbul/16.3.377 Buchsbaum, 1998, Positron emission tomography studies of abnormal glucose metabolism in schizophrenia, Schizophr. Bull., 24, 343, 10.1093/oxfordjournals.schbul.a033331 Buchsbaum, 1982, Cerebral glucography with positron tomography, Arch. Gen. Psychiatry, 39, 251, 10.1001/archpsyc.1982.04290030001001 Buchsbaum, 1992, Fronto-striatal disorder of cerebral metabolism in never-medicated schizophrenics, Arch. Gen. Psychiatry, 49, 935, 10.1001/archpsyc.1992.01820120023005 Buchsbaum, 1992, Striatal metabolic rate and clinical response to neuroleptics in schizophrenia, Arch. Gen. Psychiatry, 49, 966, 10.1001/archpsyc.1992.01820120054008 Buchsbaum, 1996, PET and MRI of the thalamus in never-medicated patients with schizophrenia, Am. J. Psychiatry, 153, 191, 10.1176/ajp.153.2.191 Davis, 1998, Ventricular enlargement in poor-outcome schizophrenia, Biol. Psychiatry, 43, 783, 10.1016/S0006-3223(97)00553-2 Delis, 1987 DeLisi, 1989, Increased temporal lobe glucose use in chronic schizophrenie patients, Biol. Psychiatry, 25, 835, 10.1016/0006-3223(89)90263-1 DeLisi, 1997, Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia, Psychiatry Res. Neuroimaging, 74, 129, 10.1016/S0925-4927(97)00012-7 Dixon, 1981 Friston, 1995, Commentary and opinion: II. Statistical parametric mapping: ontology and current issues, J. Cereb. Blood Flow Metabl., 15, 361, 10.1038/jcbfm.1995.45 Garmezy, 1970, Process and reactive schizophrenia: some conceptions and issues, Schizophr. Bull., 2, 4 Geider, 1982 Goldman-Rakic, P.S., Selemon, L.D., 1986. Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In Jones, E.G., Peters, A. (Eds.), Cerebral Cortex, Vol. 5. Plenum Publishing Company, New York, pp. 447–466. Gur, 1995, Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features, Arch. Gen. Psychiatry, 52, 657, 10.1001/archpsyc.1995.03950200047013 Harris, 1991, Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease, Psychiatry Res. Neuroimaging, 40, 167, 10.1016/0925-4927(91)90008-E Haznedar, 1997, Anterior cingulate gyrus volume and glucose metabolism in autistic disorder, Am. J. Psychiatry, 154, 1047, 10.1176/ajp.154.8.1047 Kawasaki, 1996, Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures, Psychiatry Res. Neuroimaging, 67, 49, 10.1016/0925-4927(96)02685-6 Keefe, 1987, Characteristics of very poor outcome schizophrenia, Am. J. Psychiatry, 144, 889, 10.1176/ajp.144.7.889 Keefe, 1996, Clinical characteristics of Kraepelinian schizophrenia: extension and replication of previous findings, Am. J. Psychiatry, 153, 806, 10.1176/ajp.153.6.806 Klemm, 1996, Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression — a study with single photon emission computed tomography, Psychiatry Res. Neuroimaging, 68, 1, 10.1016/S0925-4927(96)02837-5 Matsui, 1978 Nair, 1997, Progression of cerebroventricular enlargement and the subtyping of schizophrenia, Psychiatry Res. Neuroimaging, 74, 141, 10.1016/S0925-4927(97)00013-9 National Institute of Mental Health, 1976. Abnormal Involuntary Movements Scale developed by the Psychopharmacology Research Branch. In: Guy, W. (Ed.), ECDEU Assessment Manual for Psychopharmacology, DHEW Publication No. [ADM] 76-33 8, Superintendent of Documents, US Government Printing Office, Washington, DC. Overall, 1962, Brief Psychiatric Rating Scale, Psychol. Rep., 799, 10.2466/pr0.1962.10.3.799 Pelizzari, 1989, Accurate three-dimensional registration of CT, PET, and/or MR images of the brain, J. Comput. Assist. Tomogr., 13, 20, 10.1097/00004728-198901000-00004 Poline, 1993, Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters, J. Cereb. Blood Flow Metab., 13, 425, 10.1038/jcbfm.1993.57 Roland, 1993, Three-dimensional analysis of clustered voxels in 15O-butanol brain activation images, Hum. Brain Mapp., 1, 3, 10.1002/hbm.460010103 SAS Institute, Inc., 1990. SAS User's Guide: Statistics. SAS, Cary, NC. Schröder, 1993, Can ventricular enlargement predict treatment response in schizophrenia?, Br. J. Psychiatry, 163, 13, 10.1192/S0007125000292428 Schröder, 1994, Patterns of cortical activity in schizophrenia, Psychol. Med., 24, 947, 10.1017/S0033291700029032 Schröder, 1996, Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia, Schizophr. Res., 19, 41, 10.1016/0920-9964(95)00043-7 Schröder, 1998, D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment, Biol. Psychiatry, 43, 660, 10.1016/S0006-3223(97)00442-3 Shihabuddin, 1998, Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task, Arch. Gen. Psychiatry, 55, 235, 10.1001/archpsyc.55.3.235 Siegel, 1993, Cortico-striatal-thalamic circuits and brain glucose metabolic activity in 79 unmedicated male schizophrenics, Am. J. Psychiatry, 150, 1325, 10.1176/ajp.150.9.1325 Talairach, 1988 Volkow, 1986, Brain organization in schizophrenia, J. Cereb. Blood Flow Metab., 6, 441, 10.1038/jcbfm.1986.77